Free Stock Tips
Tips, tactics and strategies
Buy PharmaCyte Biotech
In: Tips
29 Jun 2015Hi Everybody,
If you’ve traded OTC stocks for a while, you know biotechs tend to lead the sector and produce the largest gainers.
Everyday there’s a new biotech running, creating profit opportunities for savvy traders.
With this in mind we found a nice looking biotech, that has proven to be a winner in the past.
This company has continued to release huge news since we last covered it and the stock is back in a nice range to enter for a winning trade.
Our alert for Monday is:
PharmaCyte Biotech, Inc.
Ticker symbol: PMCB
Last price: $0.109
PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).
PMCB’s patented Cell-in-a-Box treatment, has earned FDA ‘orphan drug designation’, for the treatment of pancreatic cancer. They will be executing Phase 2b of their clinical trials vs. a treatment using Eli Lilly’s Gemzar and Celgene’s Abraxane®.
Celgene is a billion dollar market cap company, and Eli Lilly is even bigger. If PMCB’s trials are successful the result could be a wild ride for early investors.
PMCB’s research partner, the university of Northern Colorado (UNC), successfully obtained a Schedule 1 license from the DEA allowing the company to continue development of treatment by utilizing cannabinoid prodrugs in combination with Cell-in-a-Box®. Now PMCB can dive deeper into experiments using cannabinoids.
In other recent news, PMCB showcased their technology and treatments to the media, large biotechnology firms and institutional investors at the 2015 BIO International Convention June 15th-18th. The convention is the world’s largest biotechnology gathering with over 40,000 people attending.
According to the CEO, they were very busy at the convention with one meeting after another.
The prospects of PMCB continue to improve almost daily.
But even before the big break in their business, the sheer potential of this story as it makes its rounds could make for some major price swings.
The smallcap biotech sector is leading the market, and PMCB is a beautiful opportunity capitalizing on this trend.
The stock looks to be set for another run.
Make sure you’re ready to book your profits with PMCB!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: Abraxane, biotechnology, buy, Cancer, Celgene, Cell-in-a-Box, diabetes, Gemzar, PharmaCyte Biotech, PMCB
Buy Cybergy Holdings
In: Tips
17 Jun 2015Hi Everybody,
We have an alert you need to see to believe, a stock which has an EPS of over $5 per share and is trading at 44 cents!
To put that in perspective most stocks trade at a multiple of their EPS, which is called the “P/E ratio”. On the Russell 2000 small cap index, the average P/E ratio is 80. If this stock was trading at 80 times its EPS it would be $408 a share. It is currently trading at 44 cents!
This is the definition of undervalued.
Fast Facts;
• This company has approximately 100 employees in 3 divisions.
• 2015 net profit of $104 million.
• They plan on uplisting to Nasdaq which requires a $4 stock price.
Our alert for Wednesday is:
Cybergy Holdings, Inc.
Ticker symbol: CYBG
Last price: $0.44
Cybergy Holdings, Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.
5 reasons investors should be excited about CYBG;
1. CYBG posted $104 million in net profit, making its EPS $5.10. If it were to trade at the average P/E Ratio of Russell 2000 stocks it would be $408 a share!
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG Labs expects to release its cyber security platform SmartFile in 2015.
5. CYBG announced it plans to uplist to NASDAQ. (Nasdaq requires a $4 price to qualify).
There’s really not much to say here other than this stock is seriously undervalued, and any shares bought in this range could give investors their biggest win of the year.
Make sure you’re ready to book your profits with CYBG!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy Pure Hospitality Solutions
In: Tips
15 Jun 2015Hi Everybody,
Online travel is huge right? The internet has forever changed the way people make flight and hotel reservations.
The big boys in the online travel industry are snapping up small regional player’s like Trivago and Agoda which puts our alert for Monday right in the cross hairs of these corporate hunters looking for bargains.
Our alert for Monday is:
Pure Hospitality Solutions, Inc.
Ticker symbol: PNOW
Last price: $0.0021
PNOW has launched Oveedia which is to the Central American-Caribbean region what Trivago was to Germany before Expedia’s $600+ million acquisition, or Thailand’s Agoda which was purchased by Priceline.
If you’re going to pick a niche region to operate a travel booking engine, the Central American-Caribbean is the place to be. The Latin America travel market is estimated at $30+ billion, estimated to reach $80 billion by 2016 according to eMarketer.
And that’s not all…
PNOW has joined Sabre Travel Network, a $7 billion NASDAQ company trading under the symbol SABR.
Sabre’s Travel Network family is comprised of companies such as American Airlines, American Express, Expedia, JetBlue, Travelocity and more.
PNOW’s Oveedia now has access to more than 125,000 hotels, 400 airlines, 16 cruise lines and 25 car rental selections through Sabre.
PNOW is also in the process of retiring debt aggressively, already retiring $4m and on it’s way to retiring 90% of their debt.
There is no denying PNOW is a very interesting acquisition candidate for the big boys in online travel, owning shares in this price range could bring HUGE returns.
Make sure you’re ready to book your profits with PNOW!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, Oveedia, PNOW, Pure Hospitality Solutions, Sabre
Buy Tanaris Power Holdings
In: Tips
4 Jun 2015Hi Everybody,
Our alert for Thursday is:
Tanaris Power Holdings Inc.
Ticker symbol: TPHX
Last price: $0.19
Let’s take a quick look at the highlights;
1. They operate in an industry expected to grow from $5.7 billion to $24 billion over the next decade.
2. Their proprietary technology is up to 40% better than currently available products.
3. The stock chart is screaming breakout.
TPHX-Tanaris Power develops Smart lithium-ion batteries and power solutions for various industrial applications. They design, engineer and produce some of the world’s safest, highest performance, most reliable and flexible lithium-ion batteries.
TPHX’s lithium-ion batteries offer numerous benefits over conventional lead-acid batteries, including;
• Significantly improved vehicle performance
• Significantly longer runtime between charges
• 3x to 5x longer lifespan than lead-acid batteries
• 65-70% less weight than similar lead-acid packs
• Completely maintenance free operation
Clearly the market is excited about the safety, reliability, performance, and flexibility of lithium ion batteries. As more vehicles and technologies make the switch, companies like TPHX will benefit.
TPHX chart screams breakout
When it comes to making money in the OTC market, look for stocks with great stories and a chart that says ‘this stock should be moving soon’, and that is exactly what we have with TPHX.
TPHX looks like it is getting ready to break out to the upside. After a hard sell off in April, the stock spent much of May consolidating and just last week the stock appears to have put in a low at 15 cents investors are rallying off of.
The volume and price has been on the rise and that’s a great sign because it tells us that the bulls are gaining control again.
So what we have here may be the perfect storm for traders looking to make some money.
• TPHX is in a hot industry.
• Their product offers clear advantages and benefits over current technology.
• The stock looks ready to rally.
We are looking at a couple of areas as logical exit areas.
• Target #1 is 45 cents. This would be a 50% pullback from the high of 75 cents and the low of 15 cents. That would be a 136% price gain.
• Target #2 is 75 cents. This represents a 100% pullback to the highs of the last move and would represent almost a 300% price gain.
Regardless of where your target is, remember, selling is harder than buying. Setting targets will make it easier to pull the trigger to get out.
Make sure you’re ready to book your profits with TPHX!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: batteries, buy, lithium-ion, power, Tanaris Power Holdings, TPHX
Buy Cybergy Holdings
In: Tips
19 May 2015Hi Everybody,
Our alert for Monday is:
Cybergy Holdings, Inc.
Ticker symbol: CYBG
Last price: $1.32
Fast Facts
• This company has approximately 100 employees in 3 divisions
• 2014 revenue $32 million
• They plan on uplisting to Nasdaq which requires a $4 stock price.
Cybergy Holdings, Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.
Why investors will be excited about CYBG…
1. CYBG posts 140% increase in contracts between 2014 and 2013.
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and
Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG labs expects to release its cyber security platform SmartFile in 2015.
Make sure you’re ready to book your profits with CYBG!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, Cybergy Holdings, CYBG, renewable energy, security, SmartFile
Buy GrowBLOX Sciences
In: Tips
13 May 2015Hi Everybody,
Our alert for Wednesday is:
GrowBLOX Sciences, Inc.
Ticker symbol: GBLX
Last price: $0.37
GrowBLOX Sciences, Inc. GBLX is a biopharmaceutical research and development company.
GBLX produces a technology called the “GrowBLOX”. The GrowBLOX is a new technology for marijuana growers.
GBLX’s GrowBLOX enables each plant to produce from 1 to 1½ pounds of marijuana every eight to twelve weeks.
No other product on the market is capable of achieving such an abundant yield per plant indoors.
GrowBLOX™ chambers are illuminated using energy-efficient LED lights and supplemented with magnetic induction lights for optimal growth at the lowest cost.
GBLX’s integrated, intelligent control system continuously monitors, manages, records, and analyzes the operation for optimal growth.
Remote-access capabilities let growers make real-time adjustments while they are on-the-go from their smartphone or computer.
GrowBLOX’s™ AeroVAPOR™ misting system delivers all of the moisture, nutrients, and oxygen that cannabis plants need to grow fast.
All of these features makes GBLX’s product a potentially huge seller in the marijuana marketplace…a marketplace that is growing larger by the day. Due to it’s ability to produce more with less, the company could find itself as the new standard bearer in grow technology, which could lead to some major revenues for this company.
Make sure you’re ready to book your profits with GBLX!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy Axxess Pharma
In: Tips
6 May 2015Hi Everybody,
Our alert for Wednesday’s business has quite a few things going for it:
• Aggressive marketing
• Strong consumer goods distribution
• Expanded global sales into Asia
• Presentations of their product line at the nation’s largest fitness expo
• Purchase orders from Australian distributors
• Promotions on a nationally live sporting syndicate
Our alert for Wednesday is:
Axxess Pharma, Inc.
Ticker symbol: AXXE
Last price: $0.078
AXXE is a specialty pharmaceutical and nutritional supplements company.
AXXE is one of those companies that you read about that graduate from the OTC and make the leap into NASDAQ or another big board exchange.
Less than a week ago AXXE announced that they have been approved by Canada’s leading health product franchise “Nutrition House” to sell its full line of Tapout products. The Tapout products will be available in over 60 high profile shopping centers across Canada by early summer.
With so much positive news and proof of their recent success, we won’t overload you in this report with all of them, but we encourage you take a look at their constant awesome news. Just head over to your quotation system of choice and take a look at the litany of positive announcements this company’s been making.
Life sciences sector growth correlates highly with countries’ general economic strength and health care spending levels. In 2013, global health care spending increased around 2.8 percent after decreasing in 2012; the Economist Intelligence Unit (EIU) expects that growth to accelerate by an annual average of 5.2 percent in 2014-2018 as the global economy continues to recover from recession.
AXXE looks like it’s at the bottom of a channel, meaning shares bought here could result in some easy profits rather quickly.
Make sure you’re ready to book your profits with AXXE.
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Hi Everybody,
Acting on big news before the rest of the market has a chance to jump on is a sure fire way to make big bucks in the stock market.
So with that in mind, we have a money making idea everyone should take a look at.
This company just announced today their product will be rolling out to 400 stores next month and you are among the first to hear about it, so that puts you in the perfect position to get in early and make big money.
Our alert for Tuesday is:
Flasr, Inc.
Ticker symbol: FLSR
Last price: $0.12
FLSR is a tobacco accessory producer, targeting moist snuff users in the U.S.
FLSR’s unique product looks to serve this growing consumer base with their products.
While that may not sound so exciting, it is. Sales of smokeless tobacco products are on the rise and are expected to total about $7 billion in 2015 according to Morningstar.
FLSR’s first product, a 4-oz. pocket-size, portable tobacco flask, with unique bottle designs and revolutionary thumb-lok twist cap is starting to hit shelves.
Do you know anyone that chews tobacco? Have you ever seen them walking around with bottles of brown spit? Gross right? Well, FLSR’s flask will put an end to all that.
FLSR’s product will be available for the first time in 400 stores in the United States beginning June 2015.
That’s only a few weeks away! With product hitting the shelves soon, it won’t be long before we start getting headlines on sales.
Just like vaporizer and e-cig companies have been benefiting from the increased aversion amongst the public consciousness to cigarette smoking, the chewing tobacco market is taking off as well.
At this low price, with the massive national rollout and increased awareness, FLSR provides traders with a nice profit opportunity.
Make sure you’re ready to book your profits with FLSR.
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy Cybergy Holdings
In: Tips
20 Apr 2015Hi Everybody,
Our alert for Monday is:
Cybergy Holdings Inc.
Ticker symbol: CYBG
Last price: $1.79
Cybergy Holdings Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.
CYBG Fast Facts
• Headquartered in Englewood, Colorado
• Approximately 100 employees
• 3 divisions
• 2014 revenue $32 million
5 reasons investors are excited about CYBG
1. CYBG posts 140% increase in contracts between 2013 and 2014.
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG Labs expects to release its cyber security platform SmartFile in 2015.
5. CYBG announced it plans to uplist to NASDAQ. (Nasdaq requires a $4 price to qualify)
Make sure you’re ready to book your profits with CYBG!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, Cybergy Holdings, CYBG, renewable energy, security, SmartFile
Buy Plandai Biotechnology
In: Tips
16 Apr 2015Hi Everybody,
Winners are popping up left and right, so we found an opportunity that could bring you some profits on Thursday morning!
It’s a stock we’ve covered before that has made traders big money, and looks set to do just that again.
The exciting thing is, there was just a mini-documentary shot at their $20 million tea operation in South Africa.
This is huge because OTC investors are generally skeptical on the operations of these companies, so this video should quell the concerns many investors normally have and could attract some big long term holders, which is great for the stock price!
Our alert for Thursday is:
Plandai Biotechnology
Ticker symbol: PLPL
Last price: $ 0.23
PLPL and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video.
Watch the video here:
In the documentary, viewers get a look inside the gates of the Senteeko tea estate and see for themselves the beauty that makes up the property’s 8,000 acres. The video also highlights the many fields of tea that produce the raw material that Plandaí uses to make its highly bioavailable green tea extract, Phytofare® Catechin Complex.
PLPL’s video also visits North West University’s Potchefstroom Campus and learn first-hand, from the scientists there who put the company’s green tea extract through human clinical trials, just what bioavailability is and why getting the product into the bloodstream and keeping it there is so important to end users of Plandaí’s product or of any nutraceutical product for that matter.
The Head of the University’s Preclinical Drug Development Platform, Prof. Anne Grobler, explains PLPL’s incredible clinical trial results, and we learn more about the Pheroid technology that the company will employ to deliver its extracts deeper into the body on the cellular level.
While at Senteeko viewers get to see the company’s 30,000 square foot production facility and watch the staff at the factory turn tea leaves into a vibrant, rich emerald green colored green tea extract. In the video, both the company’s CEO and the V.P. of Sales and Marketing discuss Senteeko’s early days, the tea estate today, the production process, Plandaí’s sales and marketing efforts and its future plans with other extracts.
This video gives investors and traders a front row seat to see the potential in PLPL.
Make sure you’re ready to book your profits with PLPL!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, Phytofare, Plandai Biotechnology, PLPL